Resources

A diagnosis of metabolic syndrome does not appear to provide additional prognostic information in patients with type 2 diabetes.

Having type 2 diabetes may have one benefit, in that men with long-term diabetes may have a reduced risk of prostate cancer, according to the results of a study published in the American Journal of Epidemiology.

The newly licensed glucose-lowering agent sitagliptin phosphate (Januvia) appears safe and somewhat effective. It could become a replacement for sulfonylurea, due to its ability to control blood sugars without weight gain and hypoglycemia.

Breastfeeding in infancy appears to be associated with a reduced risk of type 2 diabetes later in life, according to a quantitative analysis of published evidence.

In patients with type 2 diabetes, a decrease in hemoglobin (Hb) is insidious and occurs predominantly in older people with chronic kidney disease and damaged large blood vessels, research suggests.

Drug costs double and triple due to the new medications that are available with out generic copies. Diabetes makes up over 33% of the Medicare Budget!

Consumption of foods and drinks with high sugar content were associated with increased risk for pancreatic cancer, according to the results of a prospective, population-based cohort study of Swedish men and women.

A single dose augmented insulin secretion and inhibited glucagon release. This single dose of vildagliptin had carryover throughout the evening and sleeping hours until the following morning.

Scientists in London have found a way to track insulin-producing islet cells after they have been transplanted, a breakthrough in the drive to find a cure for diabetes.

The scientific evidence is strong enough to justify using folic acid as a cheap and simple way of reducing heart disease and strokes, say researchers in this week’s BMJ.